α1d adrenoceptor signaling is required for stimulus induced locomotor activity

Molecular Psychiatry

Volumn 8, Issue 7, 2003, Pages 664-672

  Sadalge, A ^a   Coughlin, L ^b   Fu, H ^a   Wang, B ^a   Valladares, O ^a   Valentino, R ^c   Blendy, J A ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ST MARY'S COLLEGE OF MARYLAND   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d 125 John Morgan Building ^*  (United States)

Author keywords

1d adrenergic receptor; Amphetamine; Cocaine; Gene targeting; Mouse

Indexed keywords

ALPHA 1D ADRENERGIC RECEPTOR; AMPHETAMINE; COCAINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELLULAR DISTRIBUTION; CONDITIONING; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE DISRUPTION; GENE FUNCTION; GENE TARGETING; HIPPOCAMPUS; LACZ GENE; LOCOMOTION; MAZE TEST; MOUSE; MOUSE MUTANT; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR GENE; REST; RUNNING; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STIMULUS RESPONSE;

ALLELES; ANIMALS; AVOIDANCE LEARNING; BRAIN; BRAIN MAPPING; CHIMERA; CIRCADIAN RHYTHM; COCAINE; DEXTROAMPHETAMINE; ENVIRONMENT; EXPLORATORY BEHAVIOR; FEMALE; GENE TARGETING; LAC OPERON; LOCOMOTION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTAGENESIS, INSERTIONAL; NERVE TISSUE PROTEINS; REACTION TIME; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; ROTATION;

EID: 0041620371     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001351     Document Type: Article

References (55)

1. Clark CR, Geffen GM, Geffen LB. Catecholamines and attention. I: Animal and clinical studies. Neurosci Biobehav Rev 1987; 11: 341-352.
2. De Sarro GB, Ascioti C, Froio F, Libri V, Nistico G. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br J Pharmacol 1987; 90: 675-685.
3. Harley C. Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog Brain Res 1991; 88: 307-321.
4. Puumala T, Riekkinen P, Sr Sirvio J. Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharmacol Biochem Behav 1997; 56: 705-712.
5. Stone EA, Zhang Y, Rosengarten H, Yeretsian J, Quartermain D. Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 1999; 94: 1245-1252.
6. Stone EA, Lin Y, Itteera A, Quartermain D. Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice. Neuropharmacology 2001; 40: 254-261.
7. Pichler L, Kobinger W. Possible function of alpha 1-adrenoceptors in the CNS in anaesthetized and conscious animals. Eur J Pharmacol 1985; 107: 305-311.
8. Knauber J, Muller WE. Subchronic treatment with prazosin improves passive avoidance learning in aged mice: possible relationships to alpha1-receptor up-regulation. J Neural Transm 2000; 107: 1413-1426.
9. Shi WX, Pun CL, Zhang XX, Jones MD, Bunney BS. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J Neurosci 2000; 20: 3504-3511.
10. Taghzouti K, Simon H, Herve D, Blanc G, Studler JM, Glowinski J, LeMoal M, Tassin JP. Behavioural deficits induced by an electrolytic lesion of the rat ventral mesencephalic tegmentum are corrected by a superimposed lesion of the dorsal noradrenergic system. Brain Res 1988; 440: 172-176.
11. Tassin JP, Simon H, Herve D, Blanc G, LeMoal M, Glowinski J, Bockaert J. Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens. Nature 1982; 295: 696-698.
12. Tassin JP, Studler JM, Herve D, Blanc G, Glowinski J. Contribution of noradrenergic neurons to the regulation of dopaminergic (D1) receptor denervation supersensitivity in rat prefrontal cortex. J Neurochem 1986; 46: 243-248.
13. Tessel RE, Barrett JE. Antagonism of the behavioral effects of cocaine and d-amphetamine by prazosin. Psychopharmacology 1986; 90: 436-440.
14. Trovero F, Blanc G, Herve D, Vezina P, Glowinski J, Tassin JP. Contribution of an alpha 1-adrenergic receptor subtype to the expression of the 'ventral tegmental area syndrome'. Neuroscience 1992; 47: 69-76.
15. Trovero F, Marin P, Tassin JP, Premont J, Glowinski J. Accelerated resensitization of the D1 dopamine receptor-mediated response in cultured cortical and striatal neurons from the rat: respective role of alpha 1-adrenergic and N-methyl-D-aspartate receptors. J Neurosci 1994; 14: 6280-6288.
16. Snoddy AM, Tessel RE. Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. Eur J Pharmacol 1985; 116: 221-228.
17. Darracq L, Blanc G, Glowinski J, Tassin JP. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 1998; 18: 2729-2739.
18. Blanc G, Trovero F, Vezina P, Herve D, Godeheu AM, Glowinski J, Tassin JP. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 1994; 6: 293-298.
19. Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, Kobilka BK, Hein L. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol 1999; 56: 154-161.
20. Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D, Kobilka BK. Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem 1999; 274: 16694-16700.
21. Cavalli A, Lattion AL, Hummter E, Nenninger M, Pedrazzini T, Aubert JF, Michel MC, Yang M, Lembo G, Vecchione C, Mostardini M, Schmidt A, Beermann F, Cotecchia S. Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci USA 1997; 94: 11589-11594.
22. Rokosh DG, Simpson PC. Knockout of the α1A/C-adrenergic receptor subtype: the α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 2002; 99: 9474-9479.
23. Rohrer DK, Desai KH, Jasper JR, Stevens ME, Regula DP Jr, Barsh GS, Bernstein D, Kobilka BK. Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci USA 1996; 93: 7375-7380.
24. Link RE, Desai KH, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, Kobilka BK. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273: 803-805.
25. Susulic VS et al. Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-29492.
26. Hess HJ. Prazosin: biochemistry and structure-activity studies. Postgrad Med 1975; Special issue: 9-17.
27. 3H]prazosin binding is correlated with behavioral immobility. Eur J Pharmacol 2001; 420: 97-102.
28. Kaestner KH, Montoliu L, Kern H, Thulke M, Schutz G. Universal beta-galactosidase cloning vectors for promoter analysis and gene targeting. Gene 1994; 148: 67-70.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochemistry 1987; 162: 156-159.
30. Kaestner KH, Ntambi JM, Kelly Jr TJ, Lane MD. Differentiation-induced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 1989; 264: 14755-14761.
31. Tamura T, Sumita L, Fujino I, Aoyama A, Horikoshi M, Hoffmann A, Roeder RG, Muramatsu M, Mikoshiba K. Striking homology of the 'variable' N-terminal as well as the 'conserved core' domains of the mouse and human TATA-factors (TFIID). Nucleic Acids Res 1991; 19: 3861-3865.
32. Nolan PM, Houpt TA, Bucan M. Chemical mutagenesis and screening for mouse mutations with an altered rest-activity pattern, in Lydic, R (ed). Molecular Regulation of Aroual States. CCR Press LLC: Boca Raton, 1998, pp 143-156.
33. Paxinos G, Franklin K. The Rat Brain In Stereotaxic Coordinates. Academic Press, San Diego, 1996.
34. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001; 4: 732-738.
35. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981; 1: 876-886.
36. Hobson JA, McCarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975; 189: 55-58.
37. Geyer MA, Segal DS, Mandell AJ. Effect of intraventricular infusion of dopamine and norepinephrine on motor activity. Physiol Behav 1972; 8: 653-658.
38. Heal DJ. Phenylephrine-induced activity in mice as a model of central alpha 1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock. Neuropharmacology 1984; 23: 1241-1251.
39. Dickinson SL, Gadie B, Tulloch IF. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by D-amphetamine and apomorphine in the rat. Psychopharmacology 1988; 96: 521-527.
40. Anden NE, Strombom U. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia 1974; 38: 91-103.
41. Day HE, Campeau S, Watson Jr SJ, Akil H. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 1997; 13: 115-139.
42. Rokosh DG et al. Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D. Biochem Biophys Res Commun 1994; 200: 1177-1184.
43. Sirvio J, MacDonald E. Central alpha1-adrenoceptors: their role in the modulation of attention and memory formation. Pharmacol Ther 1999; 83: 49-65.
44. Kostowski W. Possible relationship of the locus coeruleus-hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs. Pol J Pharnac 1985; 37: 727-743.
45. McCormick DA. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci 1989; 12: 215-221.
46. Jones LS, Gauger LL, Davis JN. Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat. J Comp Neurol 1985; 231: 190-208.
47. Oddie SD, Stefanek W, Kirk IJ, Bland BH. Intraseptal procaine abolishes hypothalamic stimulation-induced wheel-running and hippocampal theta field activity in rats. J Neurosci 1996; 16: 1948-1956.
48. Nolan PM, Kapfhamer D, Bucan M. Random mutagenesis screen for dominant behavioral mutations in mice. Methods 1997; 13: 379-395.
49. Sara SJ, Dyon-Laurent C, Herve A. Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system. Brain Res Cogn Brain Res 1995; 2: 181-187.
50. Spreng M, Cotecchia S, Schenk F. A behavioral study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities. Neurobiol Learn Mem 2001; 75: 214-229.
51. Pifi C, Drobny H, Reither H, Hornykiewicz O, Singer EA. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 1995; 47: 368-373.
52. Florin SM, Kuczenski R, Segal DS. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res 1994; 654: 53-62.
53. Kuczenski R, Segal DS. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001; 296: 876-883.
54. Lindvall O, Bjorklund A, Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res 1984; 306: 19-30.
55. Drouin C et al. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 2002; 22: 2873-2884.